Common Lab Values Reference Guide

Electrolyte and Mineral Reference Values

  • Na (Sodium)

    • Reference Range: 136−145136-145

    • Clinical Significance: Principal extracellular cation governing serum osmolality, extracellular fluid volume, and neuromuscular impulse transmission.

    • Hypernatremia (>145> 145): Commonly linked to dehydration, diabetes insipidus, excessive saline intake, or impaired thirst mechanism.

    • Hyponatremia (<136< 136): Indicates hypervolemia, syndrome of inappropriate antidiuretic hormone (SIADH) secretion, heart failure, or excessive fluid intake.

  • K (Potassium)

    • Reference Range: 3.5−53.5-5

    • Clinical Significance: Major intracellular cation responsible for resting membrane potentials, cardiac rhythm stabilization, and cellular homeostasis.

    • Hyperkalemia (>5> 5): Associated with renal impairment, cellular lysis, adrenal insufficiency, and dangerous cardiac dysrhythmias characterized by peaked T waves.

    • Hypokalemia (<3.5< 3.5): Results from gastrointestinal losses, diuretic usage, or alkalosis; can lead to muscle weakness, dysrhythmias, and flattened T waves or U waves on ECG.

  • Cl (Chloride)

    • Reference Range: 98−10698-106

    • Clinical Significance: Major extracellular anion maintaining serum tonicity, fluid balance, and acid-base equilibrium alongside sodium.

    • Hyperchloremia (>106> 106): Observed in renal tubular acidosis, metabolic acidosis, or infusion of hypertonic normal saline.

    • Hypochloremia (<98< 98): Occurs with protracted severe vomiting, nasogastric suction, or metabolic alkalosis.

  • Ca (Calcium)

    • Reference Range: 8.4−10.58.4-10.5

    • Clinical Significance: Crucial divalent cation involved in bone mineralization, cardiac and skeletal muscle excitation-contraction coupling, blood clotting, and nerve signal transmission.

    • Hypercalcemia (>10.5> 10.5): Frequently seen in primary hyperparathyroidism, malignancy, hypervitaminosis D, or prolonged immobilization.

    • Hypocalcemia (<8.4< 8.4): Leads to neuromuscular excitability, positive Chvostek or Trousseau signs, prolonged QT interval, and tetany.

  • Mg (Magnesium)

    • Reference Range: 1.5−2.51.5-2.5

    • Clinical Significance: Essential enzymatic cofactor involved in over 300 biochemical reactions, cellular ATP utilization, nucleic acid stability, and neuromuscular transmission.

    • Hypermagnesemia (>2.5> 2.5): Results in loss of deep tendon reflexes, hypotension, bradycardia, and respiratory depression.

    • Hypomagnesemia (<1.5< 1.5): Can precipitate dangerous cardiac arrhythmias (such as Torsades de Pointes), muscle tremors, and refractory hypokalemia or hypocalcemia.

  • Phos (Phosphorus / Phosphate)

    • Reference Range: 2.7−4.52.7-4.5

    • Clinical Significance: Vital for cellular energy transfer (ATP synthesis), acid-base buffering, nucleic acid structure, and bone mineral matrix formation.

    • Hyperphosphatemia (>4.5> 4.5): Typically caused by chronic kidney disease, hypoparathyroidism, or massive cellular breakdown (tumor lysis syndrome, rhabdomyolysis).

    • Hypophosphatemia (<2.7< 2.7): Causes severe muscle weakness, respiratory failure, osteomalacia, and encephalopathy due to impaired cellular ATP generation.

Hematology and Blood Cell Count Reference Values

  • Hgb (Hemoglobin)

    • Male (M) Reference Range: 14−1814-18

    • Female (F) Reference Range: 12−1612-16

    • Clinical Significance: Metalloprotein in red blood cells that binds oxygen for systemic tissue delivery and facilitates carbon dioxide transport back to the lungs.

    • Elevated Hemoglobin: Polycythemia vera, chronic hypoxic states (such as COPD or cyanotic congenital heart disease), or severe dehydration.

    • Decreased Hemoglobin: Anemia, acute or chronic hemorrhage, iron deficiency, chronic renal failure, or bone marrow suppression.

  • HCT (Hematocrit)

    • Male (M) Reference Range: 42−5242-52

    • Female (F) Reference Range: 37−4737-47

    • Clinical Significance: Volumetric percentage of red blood cells relative to total whole blood volume; typically maintains a 3:1 ratio relative to hemoglobin concentration.

    • Elevated Hematocrit: Erythrocytosis, hemoconcentration due to fluid volume deficit, or polycythemia.

    • Decreased Hematocrit: Anemia, acute blood loss, hemodilution from fluid overload, or impaired red cell production.

  • RBC (Red Blood Cells)

    • Male (M) Reference Range: 4.7−6.14.7-6.1

    • Female (F) Reference Range: 4.2−5.44.2-5.4

    • Clinical Significance: Biconcave, non-nucleated erythrocytes produced in the bone marrow essential for housing hemoglobin and transporting gases across tissue capillary beds.

    • Elevated RBC Count: Primary or secondary polycythemia, chronic hypoxia, or severe hemoconcentration.

    • Decreased RBC Count: Anemia, active hemolysis, nutritional deficiencies (vitamin B12, folate, iron), or bone marrow failure.

  • WBC (White Blood Cells)

    • Reference Range: 5000−100005000-10000

    • Clinical Significance: Primary circulating immune cells that provide cellular and humoral defense against invading pathogens, foreign antigens, and tissue injury.

    • Leukocytosis (>10000> 10000): Indicates acute bacterial or viral infection, systemic inflammation, severe trauma, physical stress, or hematologic malignancies (e.g., leukemias).

    • Leukopenia (<5000< 5000): Points to immunosuppression, viral infections, aplastic anemia, bone marrow toxicity from chemotherapy, or severe sepsis.

  • Plat (Platelets / Thrombocytes)

    • Reference Range: 150,000−300,000150,000-300,000

    • Clinical Significance: Anucleated cell fragments derived from bone marrow megakaryocytes that are essential for primary hemostasis, vascular endothelial maintenance, and initial clot formation.

    • Thrombocytosis (>300,000> 300,000): Observed in essential thrombocythemia, reactive systemic inflammation, post-splenectomy, or acute tissue damage.

    • Thrombocytopenia (<150,000< 150,000): Substantially increases risks of petechiae, ecchymosis, mucosal bleeding, and spontaneous hemorrhage; caused by immune thrombocytopenic purpura (ITP), disseminated intravascular coagulation (DIC), or bone marrow failure.

Renal Function and Metabolic Indicators

  • BUN (Blood Urea Nitrogen)

    • Reference Range: 10−2010-20

    • Clinical Significance: Measures the amount of nitrogen in the blood derived from urea, a primary breakdown product of hepatic protein metabolism filtered and excreted by the kidneys.

    • Elevated BUN (>20> 20): Indicates renal parenchymal impairment, prerenal azotemia (dehydration, hypovolemia, reduced cardiac output), upper gastrointestinal bleeding, or high catabolic states.

    • Decreased BUN (<10< 10): Correlates with severe hepatic failure, severe malnutrition, low-protein diet, or fluid volume excess.

  • Crea (Creatinine)

    • Reference Range: 0.6−1.20.6-1.2

    • Clinical Significance: Organic breakdown product of creatine phosphate in skeletal muscle, produced at a constant rate and freely filtered by the glomerulus with minimal tubular secretion or reabsorption, serving as a specific marker for renal function.

    • Elevated Creatinine (>1.2> 1.2): Direct indicator of intrinsic, prerenal, or postrenal kidney injury or chronic renal failure.

    • Decreased Creatinine (<0.6< 0.6): Associated with severe muscle atrophy, advanced debility, low muscle mass, or severe liver disease.

Urinalysis Parameters

  • UA PH (Urinalysis pH)

    • Reference Range: 4.6−84.6-8

    • Clinical Significance: Evaluates urinary hydrogen ion concentration, reflecting the metabolic acid-base status of the body and the capacity of renal tubules to maintain systemic pH balance.

    • Acidic Urine (<4.6< 4.6): Caused by high-protein diets, metabolic acidosis, uncontrolled diabetic ketoacidosis (DKA), starvation, or uric acid nephrolithiasis.

    • Alkaline Urine (>8> 8): Associated with urinary tract infections (UTIs) caused by urease-producing bacteria (such as Proteus species), vegetarian diets, metabolic alkalosis, or renal tubular acidosis.